An online GLP-1 program is not one transaction. It is a sequence of handoffs: from a questionnaire to a clinician, from a prescription to a pharmacy, and from a shipment to ongoing care. Tryozi presents that sequence as straightforward, advertising online evaluation, prescription medication, included basic labs and round-the-clock support. The useful question is not simply whether those features appear on its website, but who takes responsibility at each stage—and what happens when approval, payment or delivery does not go as expected.
Public documentation consulted October 19, 2026 identifies Tryozi Group LLC as the platform operator and places clinical care and fulfillment with clinicians and pharmacies through OpenLoop Health and affiliated medical groups. Tryozi advertises compounded injectable semaglutide and tirzepatide alongside brand-name options. Its pages provide concrete prices and several practical service details. However, promotional language about free review, no membership and cancellation sits uneasily beside policies describing immediate subscription charges, automatic renewal and a 72-hour cancellation deadline. This review traces that care pathway without treating advertising as a complete service agreement.
At a glance
- Who provides care
- Tryozi says it is a patient-management platform, not a direct medical or pharmacy provider. Its terms assign clinical care, prescribing and fulfillment to clinicians and pharmacies through OpenLoop Health and affiliated medical groups.
- Advertised compounded prices
- Compounded semaglutide injections are advertised at $79 per month and compounded tirzepatide injections at $129 per month, each labeled a lifetime deal billed monthly. Full continuation conditions are not documented.Sources: [5]
- Intake and payment tension
- The homepage advertises a free, no-obligation clinician review in one to two days; the subscription policy says the first month is charged when the intake form is completed.
- Pharmacy handoff
- OpenLoop coordinates partner pharmacies, and prescriptions may be transferred among them for fulfillment. Named partners are RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx.Sources: [3]
- Cancellation deadline
- Cancellation requests must be received at least 72 hours before billing. Missing that deadline triggers the next cycle's charge, with cancellation effective on the subsequent billing date.Sources: [8]
Start by identifying the platform, clinician and pharmacy
Tryozi Group LLC lists an address at 21113 Johnson St, Suite 101, Pembroke Pines, Florida. That identifies the business behind the platform, not necessarily the location or employer of the clinician handling a particular case. Tryozi expressly says it does not directly provide medical or pharmacy services, and that payment does not guarantee either a prescription or dispensing. Those distinctions matter before someone interprets enrollment as acceptance into treatment.
The terms place clinical care, prescribing and fulfillment with licensed clinicians and pharmacies through OpenLoop Health, Inc. and its affiliated medical groups. These are provider statements, not independently verified licensing findings. A useful next step is to obtain the treating clinician's name, clinical organization and contact route. Our guide to the clinician-platform distinction explains why the company collecting payment and the professional making treatment decisions may be different entities.
Tryozi says it currently offers services across all 50 states and Washington, D.C., but immediately qualifies that statement: some services may not be available in every jurisdiction, and coverage can change. This is not confirmation that every advertised medicine is available to every address. Readers should establish availability for their state and selected product before assuming the national service claim resolves the practical question.
| Stage | Documented responsibility | Question still worth asking |
|---|---|---|
| Platform enrollment | Tryozi manages access; its policy starts billing at completed intake. | Exactly when does this submission authorize a charge? |
| Clinical decision | Clinicians through OpenLoop and affiliated groups assess and prescribe. | Who is my treating clinician, and how do I reach that practice? |
| Dispensing | OpenLoop coordinates partner pharmacies; prescriptions may transfer. | Which pharmacy will dispense this specific prescription? |
| Delivery issue | The policy assigns incorrect-medication replacement to the pharmacy. | Who handles a warm, delayed or missing shipment? |
| Ongoing care | Tryozi advertises check-ins and 24/7 care-team access. | What is the clinical response time and scheduled follow-up plan? |
The questionnaire begins a review, not a prescription
The entry page offers a two-minute quiz to generate a personalized estimate and treatment options. The homepage describes questions about health and goals, completed entirely online without a clinic visit, followed by clinician review in one to two days. Neither the estimate nor that advertised timetable establishes approval. The documentation also does not specify whether the clinical encounter is conducted through messaging, telephone, video or another format.
Tryozi publishes general criteria of BMI at least 27, or at least 25 with a related condition, and an age range of 18–74 for new patients. These are its stated screening criteria, not an individualized eligibility determination or a universal prescribing standard. It reserves the final decision for the clinician and asks patients to disclose pregnancy, breastfeeding, medications and health conditions. Preparing a complete history is more useful than trying to predict approval from the questionnaire alone.
The payment sequence needs clarification before intake is completed. Advertising calls the review free and without obligation, but the subscription policy says access begins—and the first month is charged—when the intake form is completed. The consulted documentation does not reconcile those statements. Ask which screen constitutes enrollment, when payment is authorized, and what happens if the clinician declines treatment. The first-consultation preparation guide can help organize the clinical questions separately from the payment questions.
Identify the exact product before comparing the price
Tryozi advertises compounded semaglutide injections at $79 per month, alongside an original price of $279 and a claimed $200 saving. Its compounded tirzepatide injection offer is $129 per month, alongside $379 and a claimed $250 saving. Both product cards say “Lifetime deal” and “Billed monthly,” and describe preparation by a licensed U.S. 503A pharmacy. The broader promotion says the price is the same at every dose. These are advertised terms, not independently confirmed pharmacy or pricing guarantees.
The brand-name listings are materially different offers: Ozempic is advertised at $1,299 billed monthly, and Zepbound at $1,399 billed monthly. Both carry a warning that availability and coverage may vary. The consulted cards do not establish the dispensed presentation or package quantity for those brand-name prices. Nor do they explain whether a particular insurance arrangement changes the quoted amount. Comparing only ingredient names would miss differences in product identity, fulfillment and payment.
Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality. That fact alone does not establish clinical inequivalence or evaluate Tryozi. FDA recommends compounded drugs when an individual's medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Tryozi itself acknowledges that compounded versions have not been studied separately. A product-specific discussion is therefore more informative than treating published results for approved products as results for this program.
Labs and prescribing lead to a separate pharmacy handoff
The homepage says every plan includes licensed-clinician consultations and standard basic labs through Quest or Labcorp, covered for the patient. It also lists medication and shipping as included. Those are useful specifics, but the subscription policy says the services, labs and medications covered by the single subscription price may vary. The documentation does not identify the included tests, how often they are ordered or which circumstances could create additional costs.
For dispensing, the terms say OpenLoop coordinates partner pharmacies and may transfer prescriptions among those partners for fulfillment reasons. The named pharmacies are RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx. Naming several partners does not establish which one will serve an individual patient, which products each supplies or what state restrictions apply. It also does not establish that every named dispensing pharmacy compounds every advertised preparation.
Before shipment, ask for the dispensing pharmacy's identity, contact information and the exact product being supplied. That creates a usable route for questions about labeling, instructions and replacement rather than leaving every issue with platform support. The pharmacy-handoff guide outlines practical questions at this transition. FDA has received reports of compounded-medication measurement or administration errors, some involving hospitalization; instructions should be clarified with the prescriber or pharmacist rather than reconstructed from an online review.
The advertised week does not define the delivery guarantee
Tryozi's homepage places “Get your medication” at about a week, conditional on approval, and says the prescription ships discreetly to the patient's door. This describes an anticipated pathway, not a clearly defined arrival guarantee. The consulted documentation does not separate pharmacy preparation, dispatch, carrier transit and delivery. It also does not specify the carrier, package tracking, cold-chain arrangements or a standard response to a lost or delayed parcel.
The replacement policy is narrower than a comprehensive delivery guarantee. Damaged items may be replaced by the pharmacy after evidence of damage is received; incorrect medications will be replaced by the pharmacy. Those provisions identify a responsible party for certain problems, but do not explain every temperature, delay or loss scenario. Keeping packaging and documenting the condition of a delivery can support a concrete inquiry, without assuming that every reported problem qualifies for a refund.
FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy. That advice is regulatory context, not evidence of a Tryozi delivery problem. The practical preparation is to obtain the pharmacy's contact route and instructions before a package arrives. Our guide to warm injectable deliveries explains the FDA advice without substituting a general article for the pharmacy's handling instructions.
Ongoing support needs a clinical schedule, not just availability
Tryozi advertises ongoing check-ins and 24/7 access to the care team for as long as needed. It also says patients can reach a real person at any time. Those statements establish a support promise, but not necessarily immediate access to a prescribing clinician. The consulted pages do not define check-in frequency, consultation format, a guaranteed response time or how an administrative message becomes a clinical review.
The public contact paths are support@tryozi.com and (336) 365-0623. Before relying on those channels for continuing care, ask which team monitors them, how clinical concerns are routed and what follow-up is scheduled rather than patient-initiated. NIDDK describes follow-up as addressing treatment response and tolerability, not simply continuing payment. A subscription renewal, by itself, should not be mistaken for evidence that a clinical reassessment has occurred.
The privacy notice describes rights to obtain medical records, request corrections and confidential communications, and seek limits on sharing. It also says advertising and analytics technologies are kept off intake, quiz, account and checkout pages. Separately, the terms require consent for each SMS program; accepting the terms does not enroll someone, and promotional texts are not a purchase condition. These are useful documented controls, although this review did not audit their implementation.
Billing may run on a different clock from medication shipments
The monthly product cards do not tell the entire billing story. A homepage FAQ says that for a multi-week plan, the full plan amount shown on its card is charged once at the start, with medication then shipping every four weeks. The consulted documentation does not identify which monthly offers fall under that provision, the applicable total or the supply quantity. Four weeks is not a calendar month, and a shipping interval does not establish a minimum commitment.
Advertising says “no lock-in, no membership,” while the subscription policy describes membership and the terms provide for automatic renewal until cancellation. Charges may also include applicable taxes. Accepted methods are Visa, Mastercard, FSA/HSA, Apple Pay and Google Pay; American Express is not accepted. Listing FSA/HSA as a payment method does not establish insurance acceptance or an individual's reimbursement eligibility. No specific insurers, prior-authorization service or guaranteed coverage are documented.
The lifetime-price language also needs boundaries. The pages do not explain whether the offer survives cancellation, a treatment interruption or later reenrollment. An offer countdown discloses that it repeats every seven hours and 51 minutes, so it should not be read as a unique final deadline. Before paying, request the first charge, next charge, billing interval, shipment interval and included services in one written summary, rather than trying to reconcile separate promotional statements afterward.
Ending payments and resolving refunds are separate processes
Tryozi permits cancellation through customer service or through the online account procedure, if available. Its policy requires receipt of the request at least 72 hours before the billing date. A late request means the next cycle is charged and cancellation takes effect on the subsequent billing date. Services continue through the end of the billing cycle. That is more restrictive in practice than an unqualified reading of “cancel anytime,” even though a request can be submitted at any time.
Medical-disqualification refunds are described inconsistently. The policy introduction promises a full refund if the medical provider disqualifies the patient for any medical reason. Another clause refers to remaining subscription charges after disqualification; an FAQ says a refund may be issued. A further provision limits approved refunds to the most recent billing cycle, excluding earlier cycles. These differences prevent a confident statement that every medical denial produces the same refund.
For other cancellations, the policy says no refund will be issued. Ending future renewal therefore should not be treated as recovering money already paid. Ask for written confirmation of the effective cancellation date and any approved refund amount, particularly if medical eligibility changes after enrollment. The key unresolved issue is not whether cancellation exists, but how Tryozi applies its overlapping refund clauses to the specific stage of care and billing cycle involved.
Questions & answers
Does paying Tryozi guarantee that I will receive medication?
No. Tryozi explicitly says payment does not guarantee a prescription or dispensing. A clinician makes the treatment decision. Because the subscription policy starts billing at completed intake while advertising calls the review free, confirm the charge sequence and applicable medical-disqualification refund before submitting payment.
Are the $79 and $129 offers just introductory prices?
The consulted product cards label compounded semaglutide injections at $79 monthly and compounded tirzepatide injections at $129 monthly as lifetime deals, not expressly first-month offers. However, continuation requirements are not explained. Ask whether interruptions, cancellation, reenrollment or other changes affect the advertised rate, and whether a multi-week payment provision applies.
Can I choose which pharmacy fills my prescription?
The documentation names four partner pharmacies and says OpenLoop coordinates fulfillment, including transfers among partners. It does not establish a patient-choice process or identify the pharmacy for an individual order. Ask which pharmacy will dispense your prescription and how you will be notified if that assignment changes.
Are all lab tests included in Tryozi's price?
The homepage promises standard basic labs through Quest or Labcorp with every plan. The policy qualifies that services, labs and medications covered by the subscription price may vary. The tests and frequency are not specified, so request the included panel and circumstances that could lead to separate charges.
Does 24/7 support mean a clinician will answer immediately?
That is not established. Tryozi promises care-team access and a real person at any time, but does not document an immediate clinician response or guaranteed turnaround. Ask how support distinguishes administrative requests from clinical concerns, who responds to each and what scheduled follow-up accompanies the subscription.
How early should I request cancellation?
The policy requires the request to be received at least 72 hours before your billing date. Missing that cutoff results in another cycle's charge. Request confirmation of receipt and the effective date. Cancellation generally does not produce a refund; the separate medical-disqualification provisions contain conflicting descriptions that need clarification.
Our assessment
Tryozi documents more of its care chain than a price-only landing page: it identifies the platform operator, clinical partner structure, named pharmacy partners, lab networks, support contacts and cancellation deadline. Its advertised compounded-injection prices are concrete, and brand-name alternatives are separately priced. The weakness is coherence across those details. Free review versus intake billing, no membership versus automatic subscription renewal, universal inclusions versus variable coverage, and conflicting refund language all affect the practical care experience. Before enrolling, obtain a written account of the exact product, treating organization, dispensing pharmacy, first and subsequent charges, included labs, follow-up schedule and cancellation terms. That would make the handoffs assessable without assuming that a low advertised monthly price defines the full service.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.